David Ebel is currently an Associate Principal Scientist at Merck, where they have contributed since the company's acquisition of Cubist Pharmaceuticals in December 2014. Prior to this role, David held various positions in clinical research and operations, including Senior Clinical Manager at Ardea Biosciences/AstraZeneca and Senior Clinical Trial Manager at Cubist Pharmaceuticals. David's earlier experience includes senior roles at Elan Pharmaceuticals and Quintiles as well as serving as an Associate Scientist at Advanced Sterilization Products. David is pursuing a BS in Medical Microbiology, Microbiology, and Chemistry at California State University-Long Beach.
This person is not in the org chart
This person is not in any teams
This person is not in any offices